-
Something wrong with this record ?
COVID-19, adrenal gland, glucocorticoids, and adrenal insufficiency
E. M. Akbas, N. Akbas
Language English Country Czech Republic
Document type Journal Article, Review
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
Medline Complete (EBSCOhost)
from 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
33542545
DOI
10.5507/bp.2021.011
Knihovny.cz E-resources
- MeSH
- Adrenal Insufficiency complications drug therapy metabolism MeSH
- COVID-19 complications therapy MeSH
- Stress, Physiological MeSH
- Glucocorticoids therapeutic use MeSH
- Hormone Replacement Therapy methods MeSH
- Hospitalization MeSH
- Hydrocortisone therapeutic use MeSH
- Humans MeSH
- Disease Management MeSH
- Adrenal Glands metabolism MeSH
- Disease Progression MeSH
- SARS-CoV-2 MeSH
- Inflammation MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
The current Coronavirus disease outbreak requires that physicians work in collaboration with other physicians especially in intensive care and emergency units. To fight against this new disease, whose pathogenesis, effects, and results have not been clearly demonstrated, especially in patients with the pre-existing chronic disease, requires special expertise and perspectives. Due to the need for dynamic glucocorticoid treatment at different stages of the disease in patients with adrenal insufficiency, the existence of reports indicating that "coronavirus disease 2019" also affects the adrenal reserve, and the use of glucocorticoids also in advanced stages in patients with Coronavirus disease require this issue to be emphasized with precision. Herein, treatment of the pre-existing adrenal insufficiency in patients with actual Coronavirus disease and the effects of the this critical disease on the adrenal gland have been reviewed.
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21028016
- 003
- CZ-PrNML
- 005
- 20211129142956.0
- 007
- ta
- 008
- 211105s2021 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2021.011 $2 doi
- 035 __
- $a (PubMed)33542545
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Akbas, Emin Murat $u Erzincan Binali Yildirim University, School of Medicine, Mengucek Gazi Training and Research Hospital, Department of Endocrinology, Erzincan, Turkey
- 245 10
- $a COVID-19, adrenal gland, glucocorticoids, and adrenal insufficiency / $c E. M. Akbas, N. Akbas
- 504 __
- $a Literatura
- 520 9_
- $a The current Coronavirus disease outbreak requires that physicians work in collaboration with other physicians especially in intensive care and emergency units. To fight against this new disease, whose pathogenesis, effects, and results have not been clearly demonstrated, especially in patients with the pre-existing chronic disease, requires special expertise and perspectives. Due to the need for dynamic glucocorticoid treatment at different stages of the disease in patients with adrenal insufficiency, the existence of reports indicating that "coronavirus disease 2019" also affects the adrenal reserve, and the use of glucocorticoids also in advanced stages in patients with Coronavirus disease require this issue to be emphasized with precision. Herein, treatment of the pre-existing adrenal insufficiency in patients with actual Coronavirus disease and the effects of the this critical disease on the adrenal gland have been reviewed.
- 650 _2
- $a nadledviny $x metabolismus $7 D000311
- 650 _2
- $a adrenální insuficience $x komplikace $x farmakoterapie $x metabolismus $7 D000309
- 650 _2
- $a COVID-19 $x komplikace $x terapie $7 D000086382
- 650 _2
- $a management nemoci $7 D019468
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a glukokortikoidy $x terapeutické užití $7 D005938
- 650 _2
- $a hormonální substituční terapie $x metody $7 D020249
- 650 _2
- $a hospitalizace $7 D006760
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hydrokortison $x terapeutické užití $7 D006854
- 650 _2
- $a zánět $7 D007249
- 650 _2
- $a SARS-CoV-2 $7 D000086402
- 650 _2
- $a fyziologický stres $7 D013312
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Akbas, Nergis $u Mengucek Gazi Training and Research Hospital, Department of Obesity, Biochemistry, Erzincan, Turkey
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1213-8118 $g Roč. 165, č. 1 (2021), s. 1-7
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33542545 $y Pubmed
- 910 __
- $a ABA008 $b A 1502 $c 958 $y p $z 0
- 990 __
- $a 20211105 $b ABA008
- 991 __
- $a 20211116154951 $b ABA008
- 999 __
- $a ok $b bmc $g 1728678 $s 1148561
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 165 $c 1 $d 1-7 $e 20210204 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK118 $a Pubmed-20211105
